“Unlocking the Potential: A Recap of Viking Therapeutics’ Investors Meeting on the Obesity Market”
Viking Therapeutics: A Promising Player in the Biotech Industry Unjustified Sell-Off Viking Therapeutics, a biopharmaceutical company specializing in the development of novel therapies for metabolic and endocrine disorders, recently faced a significant setback as its stock plummeted by 50%. This drastic decline was attributed to broader market concerns surrounding GLP-1 drugs, despite Viking Therapeutics demonstrating…